Key result
APL-associated DIC is linked to substantially greater thrombin activation markers than other ANLL subtypes.
Observational (n=15)
Answers are grounded in this paper and cite their sources.
Reveals excessive vascular thrombin generation in acute promyelocytic leukemia, indicating marked hemostatic hyperactivity during induction chemotherapy.
Six patients with disseminated intravascular coagulation (DIC) in association with acute promyelocytic leukemia (APL) were studied with sensitive radioimmunoassays that are able to quantitate the extent of thrombin generation within the human circulation. The levels of prothrombin activation fragment, F1 + 2, and thrombin-antithrombin complex (TAT) were obtained at clinical presentation and were then followed serially in several patients during induction chemotherapy. The antileukemic therapy often resulted in a rise in the plasma levels of these molecular species. Simultaneous measurements of fibrinopeptide A (FPA) were also obtained, and the concentrations of this polypeptide were correlated with the levels of F1 + 2 and TAT in patients who were not receiving heparin. Nine individuals with other morphological subtypes of acute nonlymphocytic leukemia (ANLL) were investigated and were usually found to have increased levels of F1 + 2, TAT, and FPA at clinical presentation. However, the magnitude of the elevations was considerably greater and the correlation between TAT and FPA levels was stronger in APL than in ANLL. These studies provide direct evidence that patients with APL, as well as ANLL, generate excessive amounts of thrombin within their vascular system. Furthermore, the data suggest that the concentrations of F1 + 2, compared with the levels of FPA, may be a more sensitive indicator of hemostatic system hyperactivity in individuals with DIC.
No takes yet. Share an insight, caveat, or question.
Bauer et al. (1984) conducted an observational in Acute promyelocytic leukemia (APL) with disseminated intravascular coagulation (DIC) and other acute nonlymphocytic leukemia (ANLL) (n=15). Acute promyelocytic leukemia (APL) with DIC vs. Other morphological subtypes of acute nonlymphocytic leukemia (ANLL) was evaluated on Plasma levels of prothrombin activation fragment (F1+2), thrombin-antithrombin complex (TAT), and fibrinopeptide A (FPA). Patients with APL and DIC (n=6) had considerably greater elevations in F1+2, TAT, and FPA and stronger TAT-FPA correlations than patients with other ANLL subtypes (n=9).
Synapse has enriched 10 related papers. Consider them for comparative context: